*This refers to 1) experiencing shorter durations of efficacy as compared to previous treatments,
2) treatment not producing the same desired outcome and / or
3) treatment becomes totally ineffective.
Definition: the ability of the body to neutralise the Botulinum Toxin product, which consequently results in little to no visible effect after multiple rounds of treatments.
This is caused by the development of neutralising antibodies against the active neurotoxin. The risk of developing resistance may be increased by the presence of complexing proteins.
Complexing Proteins and why it is unnecessary for you
Complexing proteins are foreign bacterial proteins found within most Botulinum Toxins, initially thought to stabilise the active neurotoxin and facilitate the uptake of Botulinum Toxins into target issues.
Complexing proteins do not play an active role in treatment efficacy. However, the presence of complexing proteins may result in the formation of neutralising antibodies.#
The formation of neutralising antibodies may lead to treatment failure for avid user of Botulinum Toxin.#
Introducing The PURE Toxin with Zero Complexing Proteins
ZERO COMPLEXING PROTEINS = LOWER RISK OF NEUTRALISING ANTIBODY FORMATION